Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Sertindole on Sensory Gating and Cognition in Schizophrenic Patients

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Schizophrenia according to DSM IV~* Selected and treated in respect of the SPC (20 mg Serdolect max. and population at risk will be excluded)~Exclusion Criteria:~* DSM IV Axis I disorders other than schizophrenia: Substance-dependence (excepting nicotine-dependence and substance-abuse), recent (2 months) DSM IV diagnosis according to DIA-X of a major affective, anxiety disorder, eating-disorder.~* DSM IV Axis II disorders: Lifetime DSM IV diagnosis of personality disorder.~* ECG: QTc-interval \>450 msec.~* Systolic blood pressure \<100 mmHg~* Bradycardia (Hf \< 50/Min) und Arrhythmias~* Hypokalemia or Hypomagnesemia

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: EXPERIMENTAL): Schizophrenic patients treated with sertindole
- 2 (Type: ACTIVE_COMPARATOR): Schizophrenic patients treated with risperidone
- 3 (Type: NO_INTERVENTION): Healthy controls without any treatment.

Based on this trial design, predict the completion outcome and termination type (if applicable).